NF1, Plexiform Neurofibromas Market Research Study
04 May 2020
NF1, Plexiform Neurofibromas patient voice study, paid market research.
The purpose of the research is to help our sponsor, a pharmaceutical company, better understand how they can support people with NF1 (neurofibromatosis type 1) and PN (plexiform neurofibromas) and their caregivers. To achieve this, we would like to understand the journey yourself/the person you care for has been on in living with NF1 with PN; with the ultimate goal to help people like yourself/the person you care for in the future.
We would like to conduct a few interviews via video-call with parents/ caregivers, plus a few ‘homework’ exercises. Your total involvement will take approx. 90 minutes.
You will receive a financial reward for your participation.
Any information you provide us with will be treated confidentially and will be completely anonymous.
Taking this opportunity to have your voice heard would greatly help us further our research, and your participation would be hugely appreciated. If you want to participate or have any questions, please contact me, Jason Seymour, at Adept Field Solutions Ltd. by email Jason.seymour@adeptfield.com or call this number 0203 432 8217
More information about Adept Field Solutions can be found here: www.adeptfield.com
Many thanks in advance for your participation.
Market Research PDF
Filter News
Disclosing and explaining visible differences - CAR Workshop
Read more about the workshop, featuring additional guidance from Specialist NF Nurse Rebecca Rennison
Read MoreJo Ward’s Avastin Blog
Jo Ward, CEO of NF2 BioSolutions UK, shares a blog about her son Oscar's Avastin journey
Read MoreNigel’s story - Normal is as normal does
Nigel lived a normal life until age 47. The next 20 years took him from NF1 to NF2 to Schwannomatosis to mosaic NF2
Read MoreWorld Mental Health Day 2023
NTUK (as part of the Neurological Alliance) has signed a joint letter aimed at improving access to mental health services
Read MoreCAR Research visible difference experiences during recruitment
Research participants required, find out more and take part
Read MoreNF Academy 2023 - Ella’s Blog
Ella, who has NF1, attended the week-long 2023 NF Academy in Portugal, meeting young adults with NF from all over Europe
Read MoreUniversity of Manchester Research
Read about the latest PHD research, involving Nerve Tumours UK, at the University of Manchester
Read MoreNew Research Study for Children and Young People with NF1
Find out more about the study and how you can participate here
Read MoreNeurofibromatosis Type 2 name change
The new name for Neurofibromatosis Type 2 is NF2-related-Schwannomatosis (NF2)
Read More